<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01631643</url>
  </required_header>
  <id_info>
    <org_study_id>3093513</org_study_id>
    <nct_id>NCT01631643</nct_id>
  </id_info>
  <brief_title>One Touch速 Verio速IQ European Clinical Outcomes Study</brief_title>
  <official_title>One Touch速 Verio速IQ European Clinical Outcomes Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LifeScan</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LifeScan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the clinical benefits of One Touch VerioIQ system.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation of the clinical benefits of the One Touch VerioIQ system. The system contains
      pattern alert technology and comes with educational material (Pattern guide) which provides
      additional support and insights to patients and health care providers to help them make more
      informed decisions during blood glucose management.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Business decision to withdraw trial
  </why_stopped>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">June 2013</completion_date>
  <primary_completion_date type="Anticipated">June 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in A1C from baseline to week 24</measure>
    <time_frame>24 weeks</time_frame>
    <description>A1C (also known as hemoglobin A1C or glycosylated hemoglobin)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in A1C from baseline to week 12</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in FPG from baseline to 24 weeks</measure>
    <time_frame>24 weeks</time_frame>
    <description>FPG (Fasting plasma glucose)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in proportion of subjects with A1C less than or equal to 7.0% at week 24</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in 30 day mean glucose comparing first month to last month after 24 weeks</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Diabetes</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>One Touch VerioIQ Blood Glucose Monitor</intervention_name>
    <description>BGM with pattern alert technology and with associated pattern guide</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male or female at least 18 to 80 years old

          -  ADA guidelines for FPG and PPG appropriate

          -  A1C greater or equal to 8.0% and less than or equal to 10.5%

          -  lab A1C greater than or equal to 8.0% in the last 6-12mths

          -  Diagnosed with type 1 or 2 in at least last 1 year

          -  on stable dose of OADs for at least 3mths prior to screening

          -  willingness to test 7 BGM tests per day

          -  willing to remain on same therapy as baseline (MDI) for duration of study

        Exclusion Criteria:

          -  unlikely to be compliant to study procedures

          -  has or has currently used One Touch VerioIQ

          -  Is on fixed doses of insulin for MDI therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charles Thivolet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Lyon Sud</affiliation>
  </overall_official>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2012</study_first_submitted>
  <study_first_submitted_qc>June 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2012</study_first_posted>
  <last_update_submitted>December 6, 2012</last_update_submitted>
  <last_update_submitted_qc>December 6, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Blood glucose monitor</keyword>
  <keyword>Pattern management</keyword>
  <keyword>Pattern guide</keyword>
  <keyword>Education</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

